User: I want to come up with a molecule SMILES.
Assistant: This sounds very interesting. Should it be a special one?
User: Yes, the molecule should have a drug half life time in humans after IV administration value close to 16.000 hours.
Assistant: Ok, this SMILES has a drug half life time in humans after IV administration value of approximately 16.000 hours: CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O
User: I want to {#come up with|create|generate!} a {#molecule |!}{SMILES__description}.
Assistant: {#This sounds very exciting. |This sounds very interesting. !}Should it be a special {#molecule|one!}?
User: Yes, the molecule should have a {half_life_duration__names__noun} value close to {half_life_duration#} {half_life_duration__units}.
Assistant: {#Understood|Got it|Ok!}, this {SMILES__description} has a {half_life_duration__names__noun} value of approximately {half_life_duration#} {half_life_duration__units}: {SMILES#}
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione